Actavis launches generic Camptosar in European countries
This article was originally published in Scrip
Executive Summary
Irinotecan Actavis, a generic of Pfizer's Camptosar (irinotecan HCl), has been launched in the UK, France, the Netherlands, Germany, Austria and Sweden. Patents on the innovator's product expired in these markets a day before the respective launches on July 13th and 14th.